Skip to main content
. 2020 May 22;8(2):243. doi: 10.3390/vaccines8020243

Figure 5.

Figure 5

Detection of Nefmut/E7 based fusion products in transfected cells and exosomes. Shown is the Western blot analysis of total lysates from the same number of HEK293T cells transfected with DNA vectors expressing either Nefmut/E7 or GC-AG Nefmut/E7 (left panels). Equal volumes of buffer, where purified exosomes were resuspended after differential centrifugations of the respective supernatants, were also analyzed (right panel). As control, conditions from mock-transfected cells, as well as cells transfected with Nefmut alone, were included. Polyclonal anti-Nef Abs served to detect Nefmut-based products, while β-actin and Alix were revealed as markers for cell lysates and exosomes, respectively. Concerning signals from cell lysates, intensity ratios compared to the Nefmut control condition, considering the respective β-actin signals, were 1.05 and 0.91 for GC-AG Nefmut/E7 and Nefmut/E7, respectively. Regarding exosomes, the intensity ratio between Nefmut and Nefmut/E7 conditions, considering the respective Alix signals, was 0.81. Molecular markers are given in kDa. The results are representative of five independent experiments. Uncropped blots showing all the bands with all molecular weight markers are shown in Supplementary Figure S3.